Wei Jun Gu
Impact in
- Geriatrics and Gerontology top 0.01%
- Sirtuins and Resveratrol in Medicine
- Oncology top 0.1%
- Cancer-related Molecular Pathways
Papers in
- Oncology 108
- Cancer-related Molecular Pathways 105
-
- Sirtuins and Resveratrol in Medicine 24
- Co-authors
- Christopher L. Brooks (18 shared papers)Robert G. Roeder (7 shared papers)Delin Chen (19 shared papers)Ning Kon (35 shared papers)Muyang Li (17 shared papers)Le Jiang (13 shared papers)Shang-Jui Wang (9 shared papers)Richard J. Baer (5 shared papers)
- Journals
- Cell (19 papers)Journal of Biological Chemistry (17 papers)Molecular Cell (15 papers)Nature (9 papers)Cell Cycle (9 papers)
- Partner nations
- United StatesChinaCanada
In The Last Decade
Wei Jun Gu
277 papers receiving 53k citations
Wei Jun Gu's Hit Papers
Peers
Comparison fields: 5 of 147
- Geriatrics and Gerontology 4.8k
- Oncology 10k
- Endocrine and Autonomic Systems 2.3k
- Pulmonary and Respiratory Medicine 10.7k
- Molecular Biology 18.1k
Countries citing papers authored by Wei Jun Gu
This map shows the geographic impact of Wei Jun Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Jun Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Jun Gu more than expected).
Fields of papers citing papers by Wei Jun Gu
This network shows the impact of papers produced by Wei Jun Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Jun Gu. The network helps show where Wei Jun Gu may publish in the future.
Co-authors
The 25 scholars most cited alongside Wei Jun Gu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 280 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Ferroptosis as a p53-mediated activity during tumour suppression Hit paper breakdown → | 2015 | 2847 |
| 2 | Targeted Disruption of the Melanocortin-4 Receptor Results in Obesity in Mice Hit paper breakdown → | 1997 | 2603 |
| 3 | CD8+ T cells regulate tumour ferroptosis during cancer immunotherapy Hit paper breakdown → | 2019 | 2321 |
| 4 | Activation of p53 Sequence-Specific DNA Binding by Acetylation of the p53 C-Terminal Domain Hit paper breakdown → | 1997 | 2192 |
| 5 | Negative Control of p53 by Sir2α Promotes Cell Survival under Stress Hit paper breakdown → | 2001 | 1868 |
| 6 | Ferroptosis as a target for protection against cardiomyopathy Hit paper breakdown → | 2019 | 1777 |
| 7 | Modes of p53 Regulation Hit paper breakdown → | 2009 | 1390 |
| 8 | Mammalian SIRT1 Represses Forkhead Transcription Factors Hit paper breakdown → | 2004 | 1185 |
| 9 | Cysteine depletion induces pancreatic tumor ferroptosis in mice Hit paper breakdown → | 2020 | 1061 |
| 10 | Emerging Mechanisms and Disease Relevance of Ferroptosis Hit paper breakdown → | 2020 | 922 |
| 11 | Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization Hit paper breakdown → | 2002 | 862 |
| 12 | ALOX12 is required for p53-mediated tumour suppression through a distinct ferroptosis pathway Hit paper breakdown → | 2019 | 773 |
| 13 | Tumor Suppression in the Absence of p53-Mediated Cell-Cycle Arrest, Apoptosis, and Senescence Hit paper breakdown → | 2012 | 771 |
| 14 | p53 Ubiquitination: Mdm2 and Beyond Hit paper breakdown → | 2006 | 746 |
| 15 | Acetylation Is Indispensable for p53 Activation Hit paper breakdown → | 2008 | 719 |
| 16 | Brown Remodeling of White Adipose Tissue by SirT1-Dependent Deacetylation of Pparγ Hit paper breakdown → | 2012 | 712 |
| 17 | 2000 | 711 | |
| 18 | Activation of SAT1 engages polyamine metabolism with p53-mediated ferroptotic responses Hit paper breakdown → | 2016 | 666 |
| 19 | 2003 | 654 | |
| 20 | 2003 | 642 |
About Wei Jun Gu
Wei Jun Gu is a scholar working on Oncology, Geriatrics and Gerontology, Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 280 papers that have together received 54.1k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (105 papers), Ferroptosis and cancer prognosis (33 papers), Ubiquitin and proteasome pathways (32 papers), Sirtuins and Resveratrol in Medicine (24 papers), Genomics and Chromatin Dynamics (13 papers), Cancer, Lipids, and Metabolism (7 papers), Diabetes Treatment and Management (7 papers) and Cancer, Hypoxia, and Metabolism (7 papers). The work is most often cited by research in Geriatrics and Gerontology (4.8k citations), Oncology (10k citations), Endocrine and Autonomic Systems (2.3k citations), Pulmonary and Respiratory Medicine (10.7k citations) and Molecular Biology (18.1k citations). Wei Jun Gu has collaborated with scholars based in United States, China and Canada. Frequent co-authors include Christopher L. Brooks, Robert G. Roeder, Delin Chen, Ning Kon, Muyang Li, Le Jiang, Shang-Jui Wang, Richard J. Baer, Tongyuan Li and Yi Tang. Their work appears in journals such as Cell, Journal of Biological Chemistry, Molecular Cell, Nature and Cell Cycle.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.